Novo Nordisk's reports to the FDA spiked shortly after an inspection found the Ozempic producer ignored reports of deaths and potential side effects.

Some less common but serious side effects of gabapentin include suicidal thoughts, allergic reactions, and serious breathing ...

Women are more likely to survive cancer than men but face a higher risk of serious and adverse side effects from treatment, according to a landmark international study from Adelaide University.

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

Female cancer patients have increased survival but also have a higher risk for serious and adverse side effects from cancer treatment compared with men, according to a study published online Feb. 16 ...

Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO) on behalf of investors that purchased or ...

A securities class action lawsuit has been filed against Soleno Therapeutics, Inc. (NASDAQ: SLNO) seeking to represent investors who purchased Soleno common stock between March 26, 2025 and November 4 ...

U.S. regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy. The Food and Drug Administration approved a 7.2-milligram dose of Novo Nordisk's ...

Researchers found that the odds of developing an eye condition that leads to vision loss were about 5 times higher among ...

Clinical and payer strategies should treat GLP‑1 therapy as chronic for high-risk patients, addressing tolerability and cost ...

First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or ...

Kratom would be outlawed as a Schedule I substance under a bill passed Tuesday by the Iowa House. House File 2133 would ...